Aims To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world
studies including atrial fibrillation (AF) patients. Methods and results Systematic review and …

Antithrombotic drugs are widely used for primary and secondary prevention, as well as
treatment of many cardiovascular disorders. Over the past few decades, major advances in …

Новые возможности цитопротекции в лечении и профилактике заболеваний желудка и
кишечника (резолюция Экспертного совета и обзор литературы) | Мартынов …

Introduction: The emergence of the direct oral anticoagulants (DOACs) offers patients more
convenient and accessible alternatives to warfarin or parenteral agents for the treatment of …

Aim. To generalize up-to-date information on the possibilities of cytoprotection in the
treatment and prevention of gastric and intestinal diseases, as well as to present the …

Abstract Background Vitamin‐K antagonists (VKAs) have widely been replaced by non‐VKA
oral anticoagulants (NOACs). This includes Austria, Germany and Switzerland, where as …

Background: Given the huge burden of atrial fibrillation (AF) and AF-related stroke in Asia,
stroke prevention represents an urgent issue in this region. We herein performed a network …

Background The sequelae of myocardial infarction (MI) require specific pharmacological
therapy to minimise the post-MI remodelling, which in many cases evolves into …

OBJECTIVES Patients undergoing hip fracture surgery have a 10 times increased risk of
stroke compared with the general population. We aimed to evaluate the association …

При долгосрочной антитромботической терапии крайне важно обеспечить адекватную
защиту слизистой оболочки желудочно-кишечного тракта (ЖКТ) с целью …